Liver cancer treatment with immunotherapy

Immunotherapy is a way to treat cancer using the patient's immune system to recognize and fight cancer cells. It is usually used with other treatments and may be a promising option for people with advanced liver cancer who have not responded to other therapies. There are a few approaches, including monoclonal antibodies—the proteins are made to stick to other cells that can be used to find and kill malignant cells. Checkpoint inhibitors are drugs that stop cancer cells from using proteins on immune cells to hide from the immune system. They can help the immune system find, attack, and kill cancer cells. After the initial consultation and pre-treatment evaluation, the healthcare team develops a treatment plan; the patient will receive immunotherapy and be closely monitored. The benefits of immunotherapy are that it may be better than other treatments at killing cancer cells, it might cause less harm than other treatments, and patients have prolonged remission or even get rid of their cancer. Immunotherapy is often combined with other cancer treatments, such as chemotherapy or radiation therapy. It is generally considered a safe and effective treatment option but can cause side effects, such as fatigue, skin rash, and diarrhea.